Uncover key drivers, emerging technologies, and competitive movements shaping the intravenous (iv) compounding robots market from 2026–2035 with trusted insights from The Business Research Company
What was the valuation of the Automated Nucleic Acid Extraction Devices Market in 2026, and what figure is it projected to hit by 2030?
The market size for automated nucleic acid extraction devices has seen rapid growth in recent years. This market is projected to expand from $6.6 billion in 2025 to $7.32 billion in 2026, achieving a compound annual growth rate (CAGR) of 10.9%. Several factors are responsible for the historical growth, including the expansion of molecular diagnostic testing, an increase in the prevalence of infectious diseases, greater adoption of laboratory automation, a rise in clinical testing volumes, and advancements in nucleic acid chemistry.
The automated nucleic acid extraction devices market is projected for significant expansion in the coming years. This market is predicted to reach $11.05 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 10.9%. Factors driving this growth during the forecast period include the increasing need for quick diagnostic methods, greater financial commitments to genomic research, the broadening scope of personalized medicine testing, the expanding use of point-of-care molecular diagnostics, and advancements in extraction efficiency technologies. Key trends anticipated in this period encompass a greater embrace of fully automated extraction platforms, an escalating requirement for high-throughput molecular diagnostics, the increasing deployment of integrated sample-to-result systems, the wider implementation of automated lab workflows, and a heightened emphasis on contamination-free procedures.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9421&type=smp
Which Drivers Are Affecting Market Participation In The Automated Nucleic Acid Extraction Devices Market?
A rise in infectious disease cases is anticipated to drive the expansion of the automated nucleic acid extraction devices market in the future. Infectious diseases are conditions stemming from harmful microorganisms like bacteria, viruses, fungi, or parasites, which can spread, either directly or indirectly, among individuals or from animals to people. The escalation of infectious diseases, especially during worldwide health emergencies like pandemics, intensifies the demand for diagnostic testing. Automated nucleic acid extraction devices are crucial in preparing samples for molecular diagnostics, thereby assisting in the identification of viruses and bacteria. For example, data from GOV.UK, a UK public sector information platform, showed in September 2023 that during the first six months of 2023, tuberculosis (TB) cases in England saw a 7% increase relative to the corresponding period in 2022, as notifications climbed from 2,251 to 2,408. Consequently, the expanding occurrence of infectious diseases is propelling the growth of the automated nucleic acid extraction devices market.
What Segment Classifications Make Up The Automated Nucleic Acid Extraction Devices Market?
The automated nucleic acid extraction devices market covered in this report is segmented –
1) By Type: Instruments, Kits, Consumables
2) By Automation Level: Fully Automated, Semi-Automated
3) By End User: Hospitals, Diagnostic Centers, Forensic Laboratories, Pharmaceutical And Biotechnology Companies, Academic Research Institutes
Subsegments:
1) By Instruments: Automated Extractors, Liquid Handling Systems
2) By Kits: DNA Extraction Kits, RNA Extraction Kits, Viral Nucleic Acid Extraction Kits
3) By Consumables: Reagents, Columns, Tips And Tubes
Which Competitive Trends Are Impacting The Structure Of The Automated Nucleic Acid Extraction Devices Market?
Leading companies in the automated nucleic acid extraction devices market are developing innovative offerings, such as automated nucleic acid extraction workstations, to expand their customer base, boost sales, and increase revenue. An automated nucleic acid extraction workstation refers to a specialized and automated system designed for the extraction of nucleic acids, including DNA and RNA, from biological samples. For instance, in April 2023, Jiangsu Bioperfectus Technologies Co. Ltd., a China-based provider of in-vitro diagnostic products, launched the SAW-48 and Cell Nucleic Acid Extraction Kit (Magnetic Bead Method). The SAW-48 distinguishes itself as a unique in-vitro diagnostic medical device by seamlessly integrating sample loading, nucleic acid purification, and PCR setup functions into a single instrument. This innovative device can concurrently process up to 48 samples, significantly reducing the time required to obtain test results. The SAW-48 streamlines the entire process of sample loading, nucleic acid purification, and PCR setup, thereby enhancing the efficiency of STD and HPV detection. The SAW-48 and the Cell Nucleic Acid Extraction Kit collectively offer a comprehensive solution, ensuring a more efficient and streamlined approach to detecting sexually transmitted diseases and human papillomavirus.
Which Leading Companies Dominate The Automated Nucleic Acid Extraction Devices Market Share?
Major companies operating in the automated nucleic acid extraction devices market are QIAGEN N.V., PerkinElmer Inc., F. Hoffmann-La Roche AG, Analytik Jena GmbH, Thermo Fisher Scientific Inc., Accubiomed Co. Ltd., AutoGen Inc., Bioneer Corporation, Tecan Group Ltd., Merck KGaA, Becton Dickinson and Company, DiaSorin Molecular LLC, BioTeke Corporation (Wuxi) Co. Ltd., Xi’an TianLong Science and Technology Co. Ltd., Jiangsu Bioperfectus Technologies Co. Ltd., Hangzhou Bloer Technology Co. Ltd., MGI Tech Co. Ltd., Aurora Biomed Inc., Promega Corporation, Hamilton Company, Beckman Coulter Inc., Bio-Rad Laboratories Inc., Zymo Research Corporation, Agilent Technologies Inc., Danaher Corporation, Eppendorf AG, GE Healthcare Life Sciences, GenScript Biotech Corporation, Greiner Bio-One International GmbH, IntegenX Inc., MicroGEM International Company, Norgen Biotek Corp.
Access The Complete Report For Deeper Market Insights:
How Does The Automated Nucleic Acid Extraction Devices Market Perform Across Major Global Regions?
North America was the largest region in the automated nucleic acid extraction devices market in 2025. The regions covered in the automated nucleic acid extraction devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Automated Nucleic Acid Extraction Devices Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=9421&type=smp
Browse Through More Reports Similar to the Global Automated Nucleic Acid Extraction Devices Market 2026, By The Business Research Company
Nucleic Acid Extraction Instruments And Reagents Global Market Report 2026
Nucleic Acid Labeling Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/nucleic-acid-labeling-global-market-report
Dna Or Rna Sample Extraction And Isolation Global Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company